| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
13,299 |
8,558 |
$411K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,555 |
7,861 |
$232K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,818 |
6,854 |
$228K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,796 |
2,510 |
$147K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,454 |
4,914 |
$119K |
| G0378 |
Hospital observation service, per hour |
8,334 |
2,598 |
$101K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,494 |
3,054 |
$93K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,822 |
1,958 |
$89K |
| S0028 |
Injection, famotidine, 20 mg |
1,119 |
808 |
$89K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,596 |
1,415 |
$69K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,068 |
760 |
$63K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,612 |
1,913 |
$59K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,695 |
2,221 |
$58K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
3,220 |
1,538 |
$55K |
| 81001 |
|
7,537 |
6,189 |
$49K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,968 |
466 |
$48K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
2,503 |
507 |
$44K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,470 |
1,045 |
$37K |
| 81025 |
|
5,893 |
5,170 |
$33K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
877 |
730 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
2,327 |
1,131 |
$26K |
| 71045 |
Radiologic examination, chest; single view |
7,429 |
5,403 |
$24K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,121 |
908 |
$24K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,813 |
1,097 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,813 |
9,571 |
$23K |
| 82962 |
|
7,468 |
2,425 |
$23K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
687 |
463 |
$22K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,849 |
4,944 |
$21K |
| J3490 |
Unclassified drugs |
279 |
111 |
$19K |
| J1815 |
Injection, insulin, per 5 units |
828 |
342 |
$18K |
| A9270 |
Non-covered item or service |
5,173 |
1,978 |
$14K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,861 |
5,649 |
$14K |
| 84484 |
|
6,318 |
3,059 |
$12K |
| 97162 |
|
817 |
570 |
$12K |
| 87070 |
|
1,795 |
1,650 |
$12K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,748 |
1,472 |
$11K |
| 96376 |
|
2,917 |
1,399 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,678 |
3,419 |
$9K |
| 85610 |
|
4,832 |
3,291 |
$9K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,162 |
1,202 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,031 |
3,946 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,653 |
1,313 |
$8K |
| 85730 |
|
4,399 |
3,095 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,496 |
2,489 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,944 |
4,018 |
$6K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
250 |
222 |
$5K |
| 74018 |
|
1,222 |
822 |
$5K |
| 83735 |
|
2,692 |
1,587 |
$5K |
| 76801 |
|
466 |
409 |
$5K |
| 87081 |
|
2,261 |
1,657 |
$5K |
| C9113 |
Injection, pantoprazole sodium, per vial |
874 |
556 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,499 |
1,144 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
526 |
396 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
878 |
417 |
$3K |
| 83690 |
|
2,690 |
2,049 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
554 |
490 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,717 |
2,293 |
$3K |
| 83880 |
|
1,647 |
1,198 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
186 |
138 |
$3K |
| 84702 |
|
2,122 |
1,835 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
566 |
330 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
85 |
62 |
$2K |
| 85027 |
|
1,327 |
901 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,698 |
1,294 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
1,300 |
789 |
$2K |
| 87040 |
|
1,648 |
756 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,908 |
847 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
936 |
701 |
$1K |
| 87077 |
|
1,495 |
1,156 |
$1K |
| 97116 |
|
293 |
144 |
$1K |
| 87186 |
|
1,449 |
1,101 |
$1K |
| 72100 |
|
67 |
52 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,602 |
1,014 |
$1K |
| 84100 |
|
668 |
402 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,179 |
790 |
$1K |
| A4217 |
Sterile water/saline, 500 ml |
169 |
121 |
$961.69 |
| 86850 |
|
761 |
610 |
$943.35 |
| 73030 |
|
32 |
26 |
$887.65 |
| 82550 |
|
1,670 |
1,188 |
$877.16 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,261 |
1,409 |
$838.98 |
| 85379 |
|
793 |
672 |
$802.49 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
998 |
726 |
$772.15 |
| 73610 |
|
56 |
50 |
$757.18 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
173 |
119 |
$732.05 |
| 93971 |
|
49 |
41 |
$714.78 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
97 |
65 |
$637.83 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
67 |
44 |
$611.80 |
| 87430 |
|
741 |
709 |
$582.23 |
| 73564 |
|
97 |
78 |
$581.93 |
| 86900 |
|
789 |
632 |
$559.64 |
| 80061 |
Lipid panel |
91 |
68 |
$501.29 |
| 87205 |
|
1,111 |
917 |
$439.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
809 |
578 |
$433.56 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
446 |
221 |
$353.35 |
| 86901 |
|
787 |
632 |
$326.35 |
| 29125 |
|
14 |
14 |
$310.87 |
| 93970 |
|
50 |
37 |
$263.85 |
| 83605 |
|
495 |
306 |
$263.22 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
31 |
25 |
$251.05 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
438 |
325 |
$243.18 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
349 |
278 |
$241.91 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
58 |
56 |
$213.48 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
19 |
13 |
$208.33 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
12 |
$192.73 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
191 |
160 |
$191.80 |
| 73630 |
|
49 |
43 |
$182.83 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
105 |
96 |
$146.12 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
79 |
72 |
$139.24 |
| 99001 |
|
121 |
109 |
$138.41 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
79 |
72 |
$103.07 |
| 85045 |
|
251 |
158 |
$101.63 |
| 83615 |
|
57 |
40 |
$98.60 |
| 90714 |
|
124 |
93 |
$92.12 |
| 72170 |
|
16 |
12 |
$77.76 |
| 87810 |
|
394 |
374 |
$77.02 |
| 87400 |
|
74 |
70 |
$68.90 |
| 87808 |
|
467 |
434 |
$66.15 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
177 |
130 |
$23.21 |
| 97535 |
Self-care/home management training, each 15 minutes |
17 |
13 |
$21.14 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
210 |
143 |
$17.00 |
| 86140 |
|
87 |
78 |
$9.61 |
| 87185 |
|
16 |
15 |
$4.47 |
| 85651 |
|
78 |
64 |
$4.32 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
43 |
37 |
$3.44 |
| 80076 |
|
43 |
38 |
$3.17 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
179 |
123 |
$2.23 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
28 |
25 |
$1.86 |
| 73130 |
|
18 |
16 |
$1.24 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
13 |
$0.55 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
12 |
12 |
$0.55 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
85 |
48 |
$0.00 |
| 84439 |
|
46 |
39 |
$0.00 |
| 99218 |
|
72 |
32 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
22 |
13 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
33 |
29 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
15 |
13 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
46 |
12 |
$0.00 |